Acquisition positions Servier as a leader in pediatric low-grade glioma and expands its pipeline with programs targeting adult and pediatric ...
The 2026 Oncology Forum will convene service line executives from Leading Health Systems and select pharmacy leaders.
The patent cliff for Keytruda is fast approaching in the U.S. Now, as Merck & Co. increasingly looks to life after its oncology megablockbuster, the company is honing its focus on new and upcoming ...
Pharmaceutical Technology on MSN
Targeted therapies to join chemo as oncology treatment backbone
Experts agree that combination approaches, which may or may not include chemotherapy, will drive improved patient outcomes in oncology.
The FDA granted full approval encorafenib (Braftovi) in combination with cetuximab (Erbitux) and fluorouracil-based ...
Oncology projects currently take up about 40% of Pfizer’s overall R&D budget. | After steering positive key pivotal readouts for a trio of Novartis’ blockbusters, Jeff Legos is now tasked with ...
The assay is designed to encourage informed patient-physician decision-making when choosing a treatment option in localised ...
10hon MSN
HC Wainwright raises its price target on CG Oncology, Inc. (CGON) to $80 and maintains a buy rating
CG Oncology, Inc. (NASDAQ:CGON) is among the 10 Fastest Growing NASDAQ Stocks to Buy. On February 27, 2026, H.C. Wainwright raised the firm’s price target on CG Oncology, Inc. (NASDAQ:CGON) to $80 ...
Proyecto ABRAZO evaluates digital CBT to support pain management, resilience, and wellbeing in children with cancer ...
New York City Health + Hospitals opened a new oncology and infusion center at its Coney Island hospital on Friday, a facility ...
NJ Top Docs has reviewed and approved five physicians at Hunterdon Hematology Oncology for 2026. We are incredibly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results